Creative Planning
RLAY icon

Creative Planning’s Relay Therapeutics RLAY Stock Holding History

Creative Planning’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
114,131
+12,782
+13% +$186K ﹤0.01% 2032
2026
Q1 		$1.01M Buy
101,349
+15,513
+18% +$139K ﹤0.01% 2447
2025
Q4 		$726K Buy
85,836
+5,963
+7% +$42.6K ﹤0.01% 2536
2025
Q3 		$417K Buy
79,873
+7,255
+10% +$27.7K ﹤0.01% 2873
2025
Q2 		$251K Buy
72,618
+49,501
+214% +$147K ﹤0.01% 3053
2025
Q1 		$60.6K Sell
23,117
-6,415
-22% -$25.1K ﹤0.01% 3322
2024
Q4 		$122K Buy
+29,532
New +$161K ﹤0.01% 3118

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Creative Planning's RLAY Position: Q2 2026 in Review

Creative Planning increased its Relay Therapeutics (RLAY) stake by 13% in Q2 2026, buying an estimated $186K and bringing the position to 114,131 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2032.

Creative Planning first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Creative Planning held 114,131 shares of Relay Therapeutics worth $2.14M as of Q2 2026.
  • Creative Planning bought 12,782 Relay Therapeutics shares in Q2 2026, an estimated $186K.
  • Relay Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2032 holding.
  • Creative Planning first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.